印度阿尤什药物的药物警戒行动

Shweta Singh, Itika Pamnani, Sourav Rang, Rabia N. Malik, A. Punitha, Rajib Purkait
{"title":"印度阿尤什药物的药物警戒行动","authors":"Shweta Singh, Itika Pamnani, Sourav Rang, Rabia N. Malik, A. Punitha, Rajib Purkait","doi":"10.4103/ijar.ijar_12_23","DOIUrl":null,"url":null,"abstract":"Since ancient times medicinal plants are regarded as rich sources of therapeutic agents for the prevention of various diseases. Synthetic pharmaceuticals dominated the market for centuries, but in recent years, the use of traditional medical systems such as Ayurveda, Yoga, Unani, Siddha, Sowa-Rigpa, and Homoeopathy have grown significantly and their demand has increased to many folds. Particularly ever since the pandemic spread across the country, this demand is witnessed more. Most of the drugs in these systems come from nature, so they are considered safe. However, this is always not true. In such a scenario, it becomes essential to continuously monitor these medications to dispel notions about them and to build public trust on scientific lines. Pharmacovigilance is such a system, which covers activities relating to the detection, assessment, understanding, and prevention of adverse effects of drugs. The pharmacovigilance system for Ayush drugs was established in 2007 in the Indian context. To ensure effective implementation; the same program has been restructured by the Ministry of Ayush, under the Central Sector Scheme in 2017. The current program is making efforts to promote understanding, education, and inculcating reporting culture among Ayush stakeholders including health professionals and the public as well. Besides this, the program is also involved in the surveillance of misleading advertisements appearing in print and electronic media.","PeriodicalId":88901,"journal":{"name":"International journal of Ayurveda research","volume":"7 1","pages":"102 - 106"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pharmacovigilance initiative for Ayush drugs in India\",\"authors\":\"Shweta Singh, Itika Pamnani, Sourav Rang, Rabia N. Malik, A. Punitha, Rajib Purkait\",\"doi\":\"10.4103/ijar.ijar_12_23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Since ancient times medicinal plants are regarded as rich sources of therapeutic agents for the prevention of various diseases. Synthetic pharmaceuticals dominated the market for centuries, but in recent years, the use of traditional medical systems such as Ayurveda, Yoga, Unani, Siddha, Sowa-Rigpa, and Homoeopathy have grown significantly and their demand has increased to many folds. Particularly ever since the pandemic spread across the country, this demand is witnessed more. Most of the drugs in these systems come from nature, so they are considered safe. However, this is always not true. In such a scenario, it becomes essential to continuously monitor these medications to dispel notions about them and to build public trust on scientific lines. Pharmacovigilance is such a system, which covers activities relating to the detection, assessment, understanding, and prevention of adverse effects of drugs. The pharmacovigilance system for Ayush drugs was established in 2007 in the Indian context. To ensure effective implementation; the same program has been restructured by the Ministry of Ayush, under the Central Sector Scheme in 2017. The current program is making efforts to promote understanding, education, and inculcating reporting culture among Ayush stakeholders including health professionals and the public as well. Besides this, the program is also involved in the surveillance of misleading advertisements appearing in print and electronic media.\",\"PeriodicalId\":88901,\"journal\":{\"name\":\"International journal of Ayurveda research\",\"volume\":\"7 1\",\"pages\":\"102 - 106\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of Ayurveda research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/ijar.ijar_12_23\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of Ayurveda research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijar.ijar_12_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

自古以来,药用植物就被认为是预防各种疾病的丰富治疗剂来源。几个世纪以来,合成药物一直主导着市场,但近年来,传统医疗系统(如阿育吠陀、瑜伽、乌纳尼、悉达、索瓦- rigpa和顺势疗法)的使用显著增长,其需求增加了许多倍。特别是自疫情在全国蔓延以来,这种需求更加明显。这些系统中的大多数药物来自大自然,因此它们被认为是安全的。然而,这并不总是正确的。在这种情况下,有必要持续监测这些药物,以消除对它们的误解,并在科学的基础上建立公众的信任。药物警戒就是这样一个系统,它涵盖了与药物不良反应的检测、评估、了解和预防有关的活动。阿尤什药物警戒系统于2007年在印度建立。确保有效实施;2017年,阿尤什部根据中央部门计划对同一计划进行了重组。目前的方案正在努力促进阿尤什利益攸关方(包括卫生专业人员和公众)的理解、教育和报告文化。除此之外,该计划还涉及对印刷和电子媒体上出现的误导性广告的监督。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Pharmacovigilance initiative for Ayush drugs in India
Since ancient times medicinal plants are regarded as rich sources of therapeutic agents for the prevention of various diseases. Synthetic pharmaceuticals dominated the market for centuries, but in recent years, the use of traditional medical systems such as Ayurveda, Yoga, Unani, Siddha, Sowa-Rigpa, and Homoeopathy have grown significantly and their demand has increased to many folds. Particularly ever since the pandemic spread across the country, this demand is witnessed more. Most of the drugs in these systems come from nature, so they are considered safe. However, this is always not true. In such a scenario, it becomes essential to continuously monitor these medications to dispel notions about them and to build public trust on scientific lines. Pharmacovigilance is such a system, which covers activities relating to the detection, assessment, understanding, and prevention of adverse effects of drugs. The pharmacovigilance system for Ayush drugs was established in 2007 in the Indian context. To ensure effective implementation; the same program has been restructured by the Ministry of Ayush, under the Central Sector Scheme in 2017. The current program is making efforts to promote understanding, education, and inculcating reporting culture among Ayush stakeholders including health professionals and the public as well. Besides this, the program is also involved in the surveillance of misleading advertisements appearing in print and electronic media.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信